Navigation Links
Neurobiological Technologies Sets Date for Second Quarter Financial Results
Date:2/5/2008

EMERYVILLE, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NTI(R)) (Nasdaq: NTII), today announced it will release its second quarter 2008 financial results, for the quarter ended December 31, 2007, on February 8. The Company will host a conference call on February 11, 2008.

Hosting the call will be Paul E. Freiman, President and Chief Executive Officer, and Craig W. Carlson, Vice President and Chief Financial Officer. The details for the call are as follows:

Live Call:

Date: Monday, February 11, 2008

Time: 10:30 a.m. ET, 9:30 a.m. CT, 7:30 a.m. PT

Dial-in number: 877-857-6147 (U.S.) 719-325-4822 (International)

Webcast of Call:

A live webcast can be accessed online by going to:

http://investor.shareholder.com/ntii/events.cfm

The call will be archived and accessible at the same website for 90 days

Telephonic Replay:

A playback of the conference call will be available from 10:00 AM PT

February 11th through midnight February 15, 2008.

Replay number: 888-203-1112 (U.S. and Canada) / 719-457-0820

(international). Replay access code: 3898964.

About Neurobiological Technologies, Inc.

NTI is a specialty biopharmaceutical company with expertise in identifying and acquiring promising drug candidates and in designing and managing late-stage clinical trials for central nervous system conditions. The Company is currently developing Viprinex(TM) (ancrod), a novel reperfusion agent that is in pivotal Phase 3 trials for the treatment of acute ischemic stroke.


'/>"/>
SOURCE Neurobiological Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Neurobiological Technologies, Inc. Reports Retirement of Ronald E. Cape, Ph.D., from Board
2. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q1/08 Review Issued By Scimitar Equity Research, Inc.
3. Neurobiological Technologies Announces Pricing of Its $60 Million Common Stock Offering
4. Neurobiological Technologies, Inc. (Nasdaq: NTIID)
5. Neurobiological Technologies, Inc. Reports Fourth Quarter and Fiscal Year-End Financial Results for 2007 Announces 1-for-7 Reverse Stock Split
6. Neurobiological Technologies, Inc. Reports Receipt of Notice From Nasdaq
7. Emisphere Technologies to Present at BIO CEO & Investor Conference on February 12
8. Vestibular Technologies Is Awarded Contract by Major Group Purchasing Organization (GPO)
9. Healthcare Technologies Ltd. Announces the Change of its Name to "NexGen Biofuels Ltd"
10. Genelabs Technologies, Inc. Announces Resignation of President and CEO
11. Millennium Biotechnologies Group Reports 40% Sales Increase for Resurgex Product Line in Greek Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... ... October 10, 2017 , ... ... (ADC) therapeutics, today confirmed licensing rights that give it exclusive global access ... developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, an ...
(Date:10/10/2017)... SANTA CRUZ, Calif. , Oct. 10, 2017 /PRNewswire/ ... SBIR grant from the NIH to develop RealSeq®-SC (Single ... preparation kit for profiling small RNAs (including microRNAs) from ... Cell Analysis Program highlights the need to accelerate development ... "New techniques for ...
(Date:10/9/2017)... , ... October 09, 2017 , ... The award-winning American ... broadcast first quarter 2018. American Farmer airs Tuesdays at 8:30aET on RFD-TV. , ... faced with the challenge of how to continue to feed a growing nation. At ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... and applications consulting for microscopy and surface analysis, Nanoscience Instruments is now ... Analytical offers a broad range of contract analysis services for advanced applications. ...
Breaking Biology Technology:
(Date:4/5/2017)... April 5, 2017 Today HYPR Corp. ... the server component of the HYPR platform is officially ... the end-to-end security architecture that empowers biometric authentication across ... has already secured over 15 million users across the ... of connected home product suites and physical access represent ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
Breaking Biology News(10 mins):